Kainic acid-induced neurodegenerative model: potentials and limitations - Wikidata - wikimedia - TriplyDB

Kainic acid-induced neurodegenerative model: potentials and limitations

Kainic acid-induced neurodegenerative model: potentials and limitations

http://www.wikidata.org/entity/Q34355569

about

Kainic Acid-Induced Excitotoxicity Experimental Model: Protective Merits of Natural Products and Plant Extracts Immediate Epileptogenesis after Kainate-Induced Status Epilepticus in C57BL/6J Mice: Evidence from Long Term Continuous Video-EEG Telemetry Advantages of repeated low dose against single high dose of kainate in C57BL/6J mouse model of status epilepticus: behavioral and electroencephalographic studies Specific imaging of inflammation with the 18 kDa translocator protein ligand DPA-714 in animal models of epilepsy and stroke Combinations of Ashwagandha leaf extracts protect brain-derived cells against oxidative stress and induce differentiation Ginseng Rb fraction protects glia, neurons and cognitive function in a rat model of neurodegeneration Naringin Attenuates Autophagic Stress and Neuroinflammation in Kainic Acid-Treated Hippocampus In Vivo.IL-1RAcPb signaling regulates adaptive mechanisms in neurons that promote their long-term survival following excitotoxic insults.SIRT5 Deficiency Enhances Susceptibility to Kainate-Induced Seizures and Exacerbates Hippocampal Neurodegeneration not through Mitochondrial Antioxidant Enzyme SOD2.Activation of different neural precursor populations in the adult hippocampus: does this lead to new neurons with discrete functions?Neuroprotective strategies in hippocampal neurodegeneration induced by the neurotoxicant trimethyltin.The diverse roles of calcium-binding protein regucalcin in cell biology: from tissue expression and signalling to disease.Proregenerative properties of ECM molecules.The SHH/Gli pathway is reactivated in reactive glia and drives proliferation in response to neurodegeneration-induced lesions.Propolis ameliorates tumor nerosis factor-α, nitric oxide levels, caspase-3 and nitric oxide synthase activities in kainic acid mediated excitotoxicity in rat brain.Dental pulp stem cells for treating neurodegenerative diseases.Effect of magnesium sulfate on hyperthermia and pentylen-tetrazol-induced seizure in developing rats.TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.Cerebrospinal fluid protein biomarker panel for assessment of neurotoxicity induced by kainic acid in rats.Postnatal interleukin-1β enhances adulthood seizure susceptibility and neuronal cell death after prolonged experimental febrile seizures in infantile rats.Magnesium lithospermate B protects neurons from N-methyl-D-aspartic acid injury and attenuates kainic acid-induced neurodegeration in FVB mice.Brain-derived neurotropic factor and GABAergic transmission in neurodegeneration and neuroregeneration.Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases.Downregulation of 14-3-3 Proteins in a Kainic Acid-Induced Neurotoxicity Model.A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury.Pirfenidone Attenuates Microglial Reactivity and Reduces Inducible Nitric Oxide Synthase mRNA Expression After Kainic Acid-Mediated Excitotoxicity in Pubescent Rat Hippocampus.Inhibitory effects of imidazoline receptor ligands on basal and kainic acid-induced neurotoxic signalling in mice.Apolipoprotein D Overexpression Protects Against Kainate-Induced Neurotoxicity in Mice.A single dose of pirfenidone attenuates neuronal loss and reduces lipid peroxidation after kainic acid-induced excitotoxicity in the pubescent rat hippocampus.Assessment of intrinsic and extrinsic signaling pathway in excitotoxic retinal ganglion cell death.Neurotoxic Agent-Induced Injury in Neurodegenerative Disease Model: Focus on Involvement of Glutamate Receptors Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases

P2860

Q26770349-8DC6A2B6-7B7F-46A2-BC7C-08F9544B60A7 Q27303313-DE03A7A7-FC3A-49F2-A134-3E987023C5FD Q27334351-99EE905D-C5DB-4E85-B8CE-E6C0DB12419B Q28535065-B306B85B-BBCE-42D8-947B-C43294B5BBF6 Q28544672-2481A012-54C6-4484-A81C-4DA23E494C37 Q33817511-02467916-EEDE-4E0F-96ED-976F45F9B3DB Q35739474-EB18AF5F-688B-4075-9F27-224FA6BC9321 Q36612395-35C96744-8EA9-490C-80F0-A8FF5264FAF9 Q37040365-6841447F-6A36-41EC-A36A-C3C6FA45C73F Q38002805-49BD6A19-4CA4-4C1B-BEB1-13ED5974DD8F Q38062390-6A862D37-B125-4E23-B8BF-84A2BCE11202 Q38092029-85343B19-37C0-4C4B-8E42-45B0780EC550 Q38160233-B2FB312B-8FC0-4B00-AFF9-A46AE5109668 Q41491918-CB38CAC2-D92F-4533-A735-4DFCCC3EFEAB Q41813900-430407B8-EE1C-4CE4-BF01-3D81A20A5ED4 Q41922640-F6FC159E-D83E-488B-B159-E7F3AD07AE38 Q42120176-257E30EE-CADF-4098-BAE3-DCCCE9A40948 Q42320459-A13D0A90-C844-4279-BAD8-1ADCE68E1BFA Q42716996-765EB9A9-4DBA-4116-8DC2-EC1D711D0385 Q43719441-0705412C-3934-4C66-BFA4-D13D20B34E70 Q45958879-AAECB471-BC28-467A-9758-6740787E35C2 Q47116241-7EFC2D06-5ABA-484B-93CA-085E8C54D50B Q47720903-C308CAD0-0B93-4436-8CE1-1CD41BBDBA8C Q47907381-546964D0-347E-4F76-AD9F-D1BC1996616A Q48220372-81C4D283-F487-406E-9852-161AC5703105 Q48239722-4D477F4B-5DCB-4793-9F16-3402ADB6A9D4 Q48676945-B765E171-6A9C-4CBB-B43C-ABA15890CC59 Q48691393-D748387E-1BD1-48DD-B856-071E77F90340 Q48922422-44369195-D561-4B14-B01B-F7A6E257807A Q55021234-34796C6A-5AF5-4BDA-B2F6-5CBBA6C2A00C Q58694067-BB7A8D9B-482C-44CA-B1A0-4F80C95890C5 Q58799111-E7BA680F-5497-46DD-8CE7-DE8D485A8F62

P2860

Kainic acid-induced neurodegenerative model: potentials and limitations

http://www.wikidata.org/entity/Q34355569

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Kainic acid-induced neurodegenerative model: potentials and limitations

@ast

Kainic acid-induced neurodegenerative model: potentials and limitations

@en

Kainic acid-induced neurodegenerative model: potentials and limitations

@nl

type

label

Kainic acid-induced neurodegenerative model: potentials and limitations

@ast

Kainic acid-induced neurodegenerative model: potentials and limitations

@en

Kainic acid-induced neurodegenerative model: potentials and limitations

@nl

prefLabel

Kainic acid-induced neurodegenerative model: potentials and limitations

@ast

Kainic acid-induced neurodegenerative model: potentials and limitations

@en

Kainic acid-induced neurodegenerative model: potentials and limitations

@nl

P1433

Q34355569-30A058B8-487C-4495-9B2B-6CB69799780B

P1476

Q34355569-1045EB78-B8A3-4CCD-8166-4E220309CE27

P2093

Q34355569-17236009-5D0B-468F-9694-688AC88BD69C

Q34355569-5598DB30-3C28-451A-B673-C89C1F57CAB1

Q34355569-BA61F93C-DF77-48B7-A8CC-A02AA024808D

Q34355569-C79288E0-2D80-4F31-8E2A-350A895BB70D

P2860

Q34355569-09F4EC35-238B-4E3A-8325-6BCFD347C874

Q34355569-0B923F54-604F-4636-8640-DE646026E42D

Q34355569-0E6559F2-2D38-46EE-BCA1-0627256AB635

Q34355569-0E6E9F47-CB57-4239-ABA7-A50468830D2C

Q34355569-15E7CCD8-7A88-4386-8939-0461AB2D79F0

Q34355569-1694C128-BDC4-4AA3-8F38-868D75E834ED

Q34355569-183C6D34-EC71-493B-9796-32449B2E4B0E

Q34355569-187190B3-F4C2-4238-BA59-9E24244084BA

Q34355569-195174EA-EB4A-4E85-B96C-EC1CC520D950

Q34355569-19E27CBD-D8CA-449C-A28E-0BFC93CF57C6

P304

Q34355569-C2A8D65A-79D6-442A-8B64-3A18DF8961BF

P31

Q34355569-447C72FD-4384-427D-922B-E70B35934DE2

Q34355569-B522A583-F80E-4DEE-98C9-E03D21E093A7

P356

Q34355569-806EC138-82FB-45A8-9D97-9DF3A1C33B79

P478

Q34355569-659FB89C-AAAF-40ED-BAE7-197643A9C985

P577

Q34355569-E0EADB2B-D3DA-4848-8EB9-8DCB02A9811D

P5875

Q34355569-38DF1B4E-94F5-4C80-AEC0-216B9BC97569

P698

Q34355569-D2D12ACD-965B-4422-9BF8-491D3D4972C2

P921

Q34355569-48A6957C-0E68-4309-B63E-7635D7A0ACCB

Q34355569-7F85FE27-2926-4FF4-B6E7-116D191EFE98

Q34355569-8061B744-78A0-4A99-A52F-24A9302BF9DD

P932

Q34355569-61DCA009-AD84-4E0C-8EF3-2EF7F97576B0

P356

P1433

Journal of Biomedicine and Biotechnology

P1476

Kainic acid-induced neurodegenerative model: potentials and limitations

@en

P2093

Hong-Liang Zhang

http://www.w3.org/2001/XMLSchema#string

Jie Zhu

http://www.w3.org/2001/XMLSchema#string

Qi Luo

http://www.w3.org/2001/XMLSchema#string

Xiang-Yu Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Uptake of materials from the nasal cavity into the blood and brain: are we finally beginning to understand these processes at the molecular level?

A nomenclature for ligand-gated ion channels

Structural insights into the assembly and activation of IL-1β with its receptors

Differential distribution of ionotropic glutamate receptor subunits in the rat olfactory bulb

Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E(2) production and neurodegeneration in cortical and hippocampal cell cultures

Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors

Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy

Modulation of excitatory synaptic transmission in the spinal substantia gelatinosa of mice deficient in the kainate receptor GluR5 and/or GluR6 subunit

p27 small interfering RNA induces cell death through elevating cell cycle activity in cultured cortical neurons: a proof-of-concept study

Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons

P304

457079

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/457079

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49654606

http://www.w3.org/2001/XMLSchema#string

P698

21127706

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

heterocyclic compound

biomedical investigative technique

P932

2992819

http://www.w3.org/2001/XMLSchema#string